<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8EB82B70-19E6-4F2F-B833-E2E530405B8C"><gtr:id>8EB82B70-19E6-4F2F-B833-E2E530405B8C</gtr:id><gtr:name>Anglo Biopharma Limited</gtr:name><gtr:address><gtr:line1>28 Keephatch Road</gtr:line1><gtr:city>Wokingham</gtr:city><gtr:postCode>RG40 1QJ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8EB82B70-19E6-4F2F-B833-E2E530405B8C" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>8EB82B70-19E6-4F2F-B833-E2E530405B8C</gtr:id><gtr:name>Anglo Biopharma Limited</gtr:name><gtr:address><gtr:line1>28 Keephatch Road</gtr:line1><gtr:city>Wokingham</gtr:city><gtr:postCode>RG40 1QJ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>70000.0</gtr:offerGrant><gtr:projectCost>100000.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>98704.0</gtr:offerGrant><gtr:projectCost>98704.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/210A221A-5A45-496B-8FFD-8D24E05BFF85"><gtr:id>210A221A-5A45-496B-8FFD-8D24E05BFF85</gtr:id><gtr:firstName>Lee</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=132678"><gtr:id>3ECE098B-E3E7-4D2B-B42F-F1CE69AB90EA</gtr:id><gtr:title>Evaluation of the technical &amp;amp; commercial viability of developing an accelerated MERS vaccine</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>132678</gtr:grantReference><gtr:abstractText>Anglo Biopharma Ltd, a UK based british biotech startup, will assess both the commercial and technical potential of a Middle Eastern Respiratory Syndrome (MERS) vaccine. An evaluation of the commercial viability of a novel MERS vaccine towards MERS will be performed. MERS is a disease described by the director of the World Health Organisation (WHO) as a &amp;quot;a threat to the entire world&amp;quot;. Anglo Biopharma in colllaboration with the University of Reading will assess the potential of University's baculovirus platform's potential to generate novel vaccine antigen candidates.</gtr:abstractText><gtr:fund><gtr:end>2018-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2017-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>168704</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">132678</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>